News for Hims & Hers Health, Inc.. (HIMS-WT)

Stocks Analysis by MarketBeat.com (Jea Yu) covering: Eli Lilly and Company, Novo Nordisk A/S, Hims Hers Health Inc. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com

Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices (

We recently compiled a list of the 10 Stocks Drop Double Digits as Investor Caution Lingers. In this article, we are going to take a look at where Hims & Hers Health, Inc.

Financial giants have made a conspicuous bullish move on Hims & Hers Health. Our analysis of options history for Hims & Hers Health HIMS revealed 21 unusual tra...

HIMS trading within one standard deviation of its 50-day moving average

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

We recently published an article titled Jim Cramer Discusses These 12 Stocks & Says Late Selloffs Are Deliberate. In this article, we are going to take a look at where Hims & Hers Health, Inc.

We recently compiled a list of the Wall Street Optimism Spills Over to These 10 Stocks on Friday. In this article, we are going to take a look at where Hims & Hers Health, Inc.

Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. And retail traders should know. We noticed this today when the ...

In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on a late-hours market selloff. Cramer shared that he was

Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS stock is a Sell.

Hims & Hers Health targets the $4T US healthcare industry, boasting 95% y/y revenue growth & a Strong Buy rating. Click here for a post-earnings analysis.

We recently published a list of Jim Cramer on 10 Stocks With The Biggest Declines Last Week. In this article, we are going to take a look at where Hims & Hers Health, Inc.

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining around 200 points on Tuesday. The Dow traded up 0.46% to 43,661.51 while t...

Hims & Hers Health, Inc. showcases strong growth with diverse revenue streams. Discover why its stock dip offers a unique opportunity. Learn more on HIMS stock here.

Markets fell broadly Tuesday with the S&P 500 trading at five-week lows and the Nasdaq extending its three-day losing streak. The Dow Jones managed to recover midday while Wall Street digested a weaker-than-anticipated consumer confidence survey from the Conference Board, adding to concerns over the health of the U.S.

To gain an edge, this is what you need to know today. Hopium Meeting Reality Please click here for an enlarged chart of Hims & Hers Health Inc (HIMS). Note t...